22754 Federal Register / Vol. 74, No. 92 / Thursday, May 14, 2009 / Notices 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; Cellular Signaling 

and Kidney Function. 

Date: June 17, 2009. 

Time: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892, (Telephone 

Conference Call). 

Contact Person: Atul Sahai, PhD, Scientific 

Review Officer, Review Branch, DEA, 

NIDDK, National Institutes of Health, Room 

759, 6707 Democracy Boulevard, Bethesda, 

MD 20892–5452, (301) 594–2242, 

sahaia@niddk.nih.gov. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; Diabetes, 

Endocrinology, and Metabolic Disease 

Fellowships. 

Date: June 17–18, 2009. 

Time: 6 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Gaithersburg Marriott 

Washingtonian Center, 9751 Washingtonian 

Boulevard, Gaithersburg, MD 20878. 

Contact Person: Robert Wellner, PhD, 

Scientific Review Officer, Review Branch, 

DEA, NIDDK, National Institutes of Health, 

Room 757, 6707 Democracy Boulevard, 

Bethesda, MD 20892–5452, (301) 594–4721, 

rw175w@nih.gov. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; DP3 Reviews. 

Date: July 15–16, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: D. G. Patel, PhD, Scientific 

Review Officer, Review Branch, DEA, 

NIDDK, National Institutes of Health, Room 

756, 6707 Democracy Boulevard, Bethesda, 

MD 20892–5452, (301) 594–7682, 

pateldg@niddk.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: May 6, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–11238 Filed 5–13–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel, Life Course 

and Cognitive Impairment in Mexican 

Americans. 

Date: June 25, 2009. 

Time: 12 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

2C212, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: Jeannette L. Johnson, PhD, 

Scientific Review Officer, National Institute 

on Aging, National Institutes of Health, 7201 

Wisconsin Avenue, Suite 2C212, Bethesda, 

MD 20892. 301–402–7705. 

JOHNSONJ9@NIA.NIH.GOV. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel, 

Proteinopathies in ALS–Dementia. 

Date: June 29, 2009. 

Time: 10:30 a.m. to 1:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

2C212, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: William Cruce, PhD, 

Scientific Review Officer, National Institute 

on Aging, Scientific Review Branch, Gateway 

Building 2C–212, 7201 Wisconsin Ave., 

Bethesda, MD 20814. 301–402–7704. 

crucew@nia.nih.gov. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel, US–UK 

Collaborations in the Biology of Aging. 

Date: July 9–10, 2009. 

Time: 8 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites Hotel, Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Elaine Lewis, PhD, 

Scientific Review Officer, Scientific Review 

Branch, National Institute on Aging, Gateway 

Building, Suite 2C212, MSC–9205, 7201 

Wisconsin Avenue, Bethesda, MD 20892. 

301–402–7707. elainelewis@nia.nih.gov. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel, Gene Therapy 

for AD. 

Date: July 9, 2009. 

Time: 1:15 p.m. to 4:15 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

2C212, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: 

Alexander Parsadanian, PhD, Scientific 

Review Officer, National Institute on Aging, 

Gateway Building 2C/212, 7201 Wisconsin 

Avenue, Bethesda, MD 20892. 301–402– 

7703. PARSADANIANA@NIA.NIH.GOV. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel, Aging 

Disease. 

Date: July 28, 2009. 

Time: 11 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

2C212, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: Alexander Parsadanian, 

PhD, Scientific Review Officer, National 

Institute on Aging, Gateway Building 2C/212, 

7201 Wisconsin Avenue, Bethesda, MD 

20892. 301–402–7703. 

PARSADANIANA@NIA.NIH.GOV. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel, Pathways to 

Health and Illness. 

Date: July 28, 2009. 

Time: 12 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

2C212, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: Jeannette L. Johnson, 

Ph.D., Scientific Review Officer, National 

Institute on Aging, National Institutes of 

Health, 7201 Wisconsin Avenue, Suite 

2C212, Bethesda, MD 20892. 301–402–7705. 

JOHNSONJ9@NIA.NIH.GOV. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel, Mobility 

Biology and Intervention Study. 

Date: August 13, 2009. 

Time: 12 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

2C212, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact: Jeannette L. Johnson, PhD, 

Scientific Review Officer, National Institutes 


pwalker on PROD1PC71 with NOTICES
Federal Register / Vol. 74, No. 92 / Thursday, May 14, 2009 / Notices 22755 

on Aging, National Institute of Health, 7201 

Wisconsin Avenue, Suite 2C212, Bethesda, 

MD 20892. 301–402–7705. 

JOHNSONJ9@NIA.NIH.GOV. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS.) 

Dated: May 7, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–11240 Filed 5–13–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; CEBRA 

Review. 

Date: May 28, 2009. 

Time: 9 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6101 

Executive Boulevard, Rockville, MD 20852, 

(Virtual Meeting). 

Contact Person: Gerald L. McLaughlin, 

PhD, Scientific Review Administrator, Office 

of Extramural Affairs, National Institute on 

Drug Abuse, NIH, DHHS, Room 220, MSC 

8401, 6101 Executive Blvd., Bethesda, MD 

20892–8401, 301–402–6626, 

gm145a@nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; 

Biosignatures of Chronic Drug Exposure. 

Date: June 5, 2009. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Sofitel Washington DC Lafayette 

Square, 806 15th Street, Washington, DC 

20005. 

Contact Person: Jose F. Ruiz, PhD, 

Scientific Review Administrator, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, NIH, 6101 Executive Blvd., Rm. 

213, MSC 8401, Bethesda, MD 20892, 301– 

451–3086, ruizjf@nida.nih.gov. 

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel; P50 and 

P60 Centers Review. 

Date: June 9–11, 2009. 

Time: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Fairmont Washington, DC, 2401 

M Street, NW., Washington, DC 20037. 

Contact Person: Eliane Lazar-Wesley, PhD, 

Health Scientist Administrator, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, NIH, DHHS, Room 220, MSC 

8401, 6101 Executive Boulevard, Bethesda, 

MD 20892–8401, 301–451–4530, 

elazarwe@nida.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.279, Drug Abuse and 

Addiction Research Programs, National 

Institutes of Health, HHS) 

Dated: May 6, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–11248 Filed 5–13–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Amended Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the National Institute on 

Drug Abuse Special Emphasis Panel, 

May 27, 2009, 9 a.m. to May 27, 2009, 

2 p.m., Courtyard by Marriott Rockville, 

2500 Research Boulevard, Rockville, 

MD 20850 which was published in the 

Federal Register on April 24, 2009, 

Volume 74, Number 78. 

The date of the meeting was changed 

from May 19, 2009 to May 27, 2009. The 

meeting is closed to the public. 

Dated: May 6, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–11247 Filed 5–13–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Revision: 

Cognitive Neuroscience Study Section. 

Date: May 28, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Churchill Hotel, 1914 Connecticut 

Avenue, NW,. Washington, DC 20009. 

Contact Person: Judith A. Finkelstein, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5178, 

MSC 7844, Bethesda, MD 20892, 301–435– 

1249, finkelsj@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Immunology 

Integrated Review Group, Cellular and 

Molecular Immunology—B Study Section. 

Date: May 28–29, 2009. 

Time: 8:30 a.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Residence Inn Bethesda, 7335 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Betty Hayden, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4206, 

MSC 7812, Bethesda, MD 20892, 301–435– 

1223, haydenb@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, CMIB ARRA 

Competitive Revision: Immunobiology. 

Date: May 29, 2009. 

Time: 2 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Residence Inn Bethesda, 7335 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Betty Hayden, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4206, 

MSC 7812, Bethesda, MD 20892, 301–435– 

1223, haydenb@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Surgical Sciences, 

Biomedical Imaging and Bioengineering 

Integrated Review Group, Biomedical 

Imaging Technology Study Section. 

Date: May 31–June 2, 2009. 

Time: 7 p.m. to 11 a.m. 

Agenda: To review and evaluate grant 

applications. 


pwalker on PROD1PC71 with NOTICES